Veraxa Biotech AG (VRXA) at a glance

Veraxa Biotech AG (VRXA) is a mid-cap Healthcare company. It trades at $1.66, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 46/100 overall. Its strongest dimension is Safety (60/100) and its weakest is Momentum (13/100).

Price
$1.66
Market cap
$2.73B
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$1.34 to $27.36
Vestovix Score46/ 100How this works
Value
50
Growth
50
Income
40
Safety
60
Momentum
13

Other Healthcare stocks

See all